Close Menu

NEW YORK – Israeli diagnostics company NanoSynex is on a mission to shake up the market for antibiotic susceptibility testing.

Though the market is currently dominated by offerings from some major multinationals, from BioMérieux to Thermo Fisher Scientific, NanoSynex believes there is a place for its system in labs.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.